Elsevier

Brain Research

Volume 560, Issues 1–2, 27 September 1991, Pages 167-174
Brain Research

Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain

https://doi.org/10.1016/0006-8993(91)91228-SGet rights and content

Abstract

The cellular distribution of insulin-like growth factor I (IGF-I) immunoreactivity was examined in the rat brain from embryonic day 15 to maturity. IGF-I immunoreactivity was found in the perikarya of neurons distributed along the entire extension of the neuronal tube in all the embryonic ages studied (E15, E17, E19 and E21). In E21 animals, the majority of immunoreactive neurons was located in the olfactory bulb, cerebral cortex, hippocampus, striatum, diencephalon, mesencephalic colliculi, trigeminal ganglion and in motoneurons of the brainstem. In 10- and 20-day-old rats, in addition to the above areas, IGF-I immunoreactivity was also observed in capillary walls, ependymal cells, choroid plexus, glial cells and most fiber paths. In postnatal ages, immunoreactivity in neuronal somas mainly restricted to the cell nuclei. However, IGF-I immunoreactivity in the neuron cytoplasm was observed in 20-day-old rats treated with colchicine while fiber paths and neuronal cell nuclei were negative in these animals. In the telencephalon of 20-day-old rats injected with colchicine, the most intense immunoreactive neurons were observed in the olfactory bulb, cerebral cortex, tenia tecta, hippocampus, islands of Calleja, septal nuclei, striatum, endopyriform nucleus and amygdala. Most diencephalic nuclei, the substantia nigra, the mesencephalic colliculi, Purkinje cells in the cerebellar cortex and several nuclei in mesencephalon, pons and medulla oblongata were also immunoreactive. In adult rats injected with colchicine, IGF-I immunoreactivity was located in the same areas as in 20-day-old rats. The number of immunoreactive cells and the intensity of the staining was reduced in adult rats as compared to that found in young postnatal animals. Glial cells were negative in adults. The distribution of IGF-I in the developing and mature rat brain supports the proposed roles of this peptide as a neuromodulator and neurotrophic factor.

Reference (34)

  • YamaguchiF. et al.

    Insulin-like growth factor I (IGF-I) distribution in the tissue and extracellular compartment in different regions of rat brain

    Brain Research

    (1990)
  • AnderssonI.K. et al.

    Differing expression of insulin-like growth factor I in the developing and in the adult rat cerebellum

    Acta Physiol. Scand.

    (1988)
  • BaskinD.G. et al.

    Insulin and insulin-like growth factors in the CNS

    Trends Neurosci.

    (1988)
  • BerelowitzM. et al.

    Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary

    Science

    (1981)
  • DaughadayW.H. et al.

    Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

    Endocr. Rev.

    (1989)
  • D'ErcoleA.J. et al.

    Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action

  • FrankH.J.L. et al.

    Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels

    Diabetes

    (1986)
  • Cited by (168)

    • Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives

      2020, Frontiers in Neuroendocrinology
      Citation Excerpt :

      For instance, IGF-I has anabolic properties in skeletal muscle and neurotrophic effects in the central nervous system. Brain levels of IGF-I are elevated during development and reach pick levels in fetal and neonatal brain, to then decrease in adulthood (Garcia-Segura et al., 1991). Nonetheless, some brain regions associated with higher renewal or remodeling maintain certain levels of IGF-I. On the other hand, IGF-IR are widely expressed in the brain and show more stable levels of expression from development to adulthood.

    • Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

      2014, Progress in Neurobiology
      Citation Excerpt :

      Neurons synthesize IGF-1 under physiological conditions, while astrocytes produce it after local injury (Jafferali et al., 2000; Moloney et al., 2010; Salehi et al., 2008; Torres-Aleman, 2010), which may represent an active defense mechanism in degenerating parts of the brain. IGF-1R and IR densities decrease with age both in humans and rodents (Adamo et al., 1989; Daftary and Gore, 2005; Garcia-Segura et al., 1991; Jafferali et al., 2000; Rotwein et al., 1988). Controversy remains regarding the source of brain insulin.

    • Growth hormone (GH) and brain trauma

      2013, Hormones and Behavior
    View all citing articles on Scopus
    View full text